- Home
- MGRM vs PMVP Comparison
MGRM vs PMVP Comparison
Compare MGRM & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRM
- PMVP
- Stock Information
- Founded
- MGRM 2016
- PMVP 2013
- Country
- MGRM United States
- PMVP United States
- Employees
- MGRM N/A
- PMVP N/A
- Industry
- MGRM Medical/Dental Instruments
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- MGRM Health Care
- PMVP Health Care
- Exchange
- MGRM Nasdaq
- PMVP Nasdaq
- Market Cap
- MGRM 79.9M
- PMVP 55.1M
- IPO Year
- MGRM N/A
- PMVP 2020
- Fundamental
- Price
- MGRM $2.91
- PMVP $1.20
- Analyst Decision
- MGRM Strong Buy
- PMVP Strong Buy
- Analyst Count
- MGRM 1
- PMVP 1
- Target Price
- MGRM $5.40
- PMVP $5.00
- AVG Volume (30 Days)
- MGRM 49.7K
- PMVP 278.5K
- Earning Date
- MGRM 08-13-2025
- PMVP 08-07-2025
- Dividend Yield
- MGRM N/A
- PMVP N/A
- EPS Growth
- MGRM N/A
- PMVP N/A
- EPS
- MGRM N/A
- PMVP N/A
- Revenue
- MGRM N/A
- PMVP N/A
- Revenue This Year
- MGRM N/A
- PMVP N/A
- Revenue Next Year
- MGRM N/A
- PMVP N/A
- P/E Ratio
- MGRM N/A
- PMVP N/A
- Revenue Growth
- MGRM N/A
- PMVP N/A
- 52 Week Low
- MGRM $1.92
- PMVP $0.81
- 52 Week High
- MGRM $4.21
- PMVP $1.82
- Technical
- Relative Strength Index (RSI)
- MGRM 62.99
- PMVP 57.96
- Support Level
- MGRM $2.81
- PMVP $0.96
- Resistance Level
- MGRM $2.99
- PMVP $1.14
- Average True Range (ATR)
- MGRM 0.12
- PMVP 0.07
- MACD
- MGRM 0.01
- PMVP -0.00
- Stochastic Oscillator
- MGRM 80.61
- PMVP 65.28
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.